2021 Pediatric Rx, Module 4- GI Drugs
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide an up‐to‐date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
Introduction: This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours, of which 1.0 is pharmacology.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Copyright 2021 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Review current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
- Evaluate critically the safety and efficacy of GI drugs in children.
Teri Moser Woo, PhD, CPNP-PC, CNL, FAANP: Professor and Director of Nursing, Saint Martin’s University; PNP, Pediatric Urgent Care for Woodcreek Pediatrics, Puyallup, Wash.
Dr. Moser Woo has no relevant financial relationships to disclose.
- 1.00 Contact hours